MX2011012340A - Quinolinas sustituidas para uso como inhibidores del factor de crecimiento endotelial vascular (vegf). - Google Patents
Quinolinas sustituidas para uso como inhibidores del factor de crecimiento endotelial vascular (vegf).Info
- Publication number
- MX2011012340A MX2011012340A MX2011012340A MX2011012340A MX2011012340A MX 2011012340 A MX2011012340 A MX 2011012340A MX 2011012340 A MX2011012340 A MX 2011012340A MX 2011012340 A MX2011012340 A MX 2011012340A MX 2011012340 A MX2011012340 A MX 2011012340A
- Authority
- MX
- Mexico
- Prior art keywords
- vegf inhibitors
- substituted quinolines
- compound
- psoriasis
- atherosclerosis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invención se refiere a un compuesto de fórmula (I), así como también a sales del mismo farmacéuticamente aceptables y composiciones farmacéuticas que comprenden una cantidad terapéuticamente efectiva de los compuestos. El compuesto es útil en el tratamiento de cáncer, retinopatía diabética, degeneración macular relacionada con la edad, inflamación apoplejía, miocardio isquémico, aterosclerosis, edema macular y psoriasis.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09160829 | 2009-05-20 | ||
PCT/EP2010/056968 WO2010133669A1 (en) | 2009-05-20 | 2010-05-20 | Substituted quinolines for use as vegf inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2011012340A true MX2011012340A (es) | 2011-12-14 |
Family
ID=41152142
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011012340A MX2011012340A (es) | 2009-05-20 | 2010-05-20 | Quinolinas sustituidas para uso como inhibidores del factor de crecimiento endotelial vascular (vegf). |
Country Status (13)
Country | Link |
---|---|
US (1) | US20120065199A1 (es) |
EP (1) | EP2432764A1 (es) |
JP (1) | JP2012527431A (es) |
KR (1) | KR20120023807A (es) |
CN (1) | CN102625798A (es) |
AU (1) | AU2010251134A1 (es) |
BR (1) | BRPI1012859A2 (es) |
CA (1) | CA2762232A1 (es) |
EA (1) | EA201101658A1 (es) |
IL (1) | IL216408A0 (es) |
MX (1) | MX2011012340A (es) |
SG (1) | SG176167A1 (es) |
WO (1) | WO2010133669A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6069356B2 (ja) * | 2012-01-05 | 2017-02-01 | クラノテク・アクチボラグ | 線維症又は線維症関連疾患の治療に使用するための、抗血管新生性のインテグリンα5β1阻害剤であるキノリン化合物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0400284D0 (sv) * | 2004-02-10 | 2004-02-10 | Astrazeneca Ab | Novel compounds |
WO2008119771A2 (en) * | 2007-03-30 | 2008-10-09 | Clanotech Ab | Quinoline-s-carboxylic acid derivatives as tyrosine kinase inhibitors |
-
2010
- 2010-05-20 BR BRPI1012859A patent/BRPI1012859A2/pt not_active IP Right Cessation
- 2010-05-20 US US13/321,602 patent/US20120065199A1/en not_active Abandoned
- 2010-05-20 JP JP2012511290A patent/JP2012527431A/ja not_active Withdrawn
- 2010-05-20 CN CN201080033815XA patent/CN102625798A/zh active Pending
- 2010-05-20 CA CA2762232A patent/CA2762232A1/en not_active Abandoned
- 2010-05-20 EA EA201101658A patent/EA201101658A1/ru unknown
- 2010-05-20 KR KR1020117030328A patent/KR20120023807A/ko not_active Application Discontinuation
- 2010-05-20 AU AU2010251134A patent/AU2010251134A1/en not_active Abandoned
- 2010-05-20 SG SG2011085461A patent/SG176167A1/en unknown
- 2010-05-20 EP EP10723066A patent/EP2432764A1/en not_active Withdrawn
- 2010-05-20 WO PCT/EP2010/056968 patent/WO2010133669A1/en active Application Filing
- 2010-05-20 MX MX2011012340A patent/MX2011012340A/es not_active Application Discontinuation
-
2011
- 2011-11-17 IL IL216408A patent/IL216408A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20120023807A (ko) | 2012-03-13 |
IL216408A0 (en) | 2012-02-29 |
AU2010251134A1 (en) | 2011-12-08 |
BRPI1012859A2 (pt) | 2016-04-05 |
WO2010133669A1 (en) | 2010-11-25 |
EA201101658A1 (ru) | 2012-05-30 |
SG176167A1 (en) | 2011-12-29 |
CN102625798A (zh) | 2012-08-01 |
JP2012527431A (ja) | 2012-11-08 |
US20120065199A1 (en) | 2012-03-15 |
CA2762232A1 (en) | 2010-11-25 |
EP2432764A1 (en) | 2012-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018501807A1 (en) | Pyrazolopyrrolidine derivatives and their use in the treatment of diseas | |
PH12016500072A1 (en) | Piperidinyl-indole derivatives complement factor b inhibitors and uses thereof | |
EA201592256A1 (ru) | Производные имидазопирролидинона и их применение при лечении заболеваний | |
MX2015016421A (es) | Derivados de pirazolo-pirrolidin-4-ona como inhibidores de bet y su uso en el tratamiento de enfermedades. | |
IN2015DN00185A (es) | ||
SG194463A1 (en) | Glycoside derivatives and their uses for the treatment of diabetes | |
MX2016000675A (es) | Derivados de amino-metil-biarilo como inhibidores del factor de complemento d y usos de los mismos. | |
PH12015501752B1 (en) | Substituted bisphenyl butanoic phosphonic acid derivatives as nep inhibitors | |
MX2013012588A (es) | Inhibidores de cinasa. | |
MX2015016425A (es) | Derivados de pirazolo-pirrolidin-4-ona y su uso en el tratamiento de enfermedades. | |
MX364400B (es) | Compuestos de tetraciclina. | |
EA201391524A1 (ru) | Производные гликозида и их применение | |
MX2013003202A (es) | Inhibidores de oxadiazol de la produccion de leucotrienos. | |
MX2010005039A (es) | Derivados de quinolina y su uso como inhibidores de tirosina quinasa. | |
MX2016006667A (es) | Derivados de pirrolo-pirrolona y su uso como inhibidores. | |
MX2015010434A (es) | Derivados de acido bisfenil-butanoico sustituido como inhibidores de la endopeptidasa neutra (nep), con una mayor eficacia in vivo. | |
MX2011012340A (es) | Quinolinas sustituidas para uso como inhibidores del factor de crecimiento endotelial vascular (vegf). | |
TN2015000058A1 (en) | Salts of benzothiazolone compound as beta-2-adrenoceptor agonist | |
CY1116412T1 (el) | Παραγωγα κινολινης, φαρμακευτικες συνθεσεις περιεχουσες αυτα, και χρηση αυτων | |
TN2013000052A1 (en) | Oxadiazole inhibitors of leukotriene production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |